Tuani, Renalyn C.
HRN: 11-89-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CEFUROXIME 500MG (TAB)
09/15/2022
09/22/2022
ORAL
1 Tab
Q12h
PROM X 15hrs, S/P NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes